Search Results - "Lok, B.H"

Langerhans Cell Histiocytosis (LCH) in the Modern Era: Excellent Local Control With Radiation Therapy (RT) by Lok, B.H, Chelius, M.R, Yahalom, J

Get full text

Redefining True Recurrence Versus New Primary Breast Tumors Based on an Intraductal Component: An Analysis of Isolated Locoregional Recurrences Following Breast Conserving Therapy by Laird, J.H, Lok, B.H, Siu, C.T, Ho, A.Y

Get full text

The Factors Influencing the Utilization of Prophylactic Cranial Irradiation in Patients With Limited-Stage Small Cell Lung Cancer by Lok, B.H, Pietanza, M.C, Foster, A, Rudin, C.M, Perez, C.A, Ong, L, Krug, L, Rimner, A, Wu, A.J

Get full text

Palliative Radiation Therapy by the RTOG 85-02 Regimen for Incurable Primary or Metastatic Head and Neck Cancers by Lok, B.H, Jiang, G, Gutiontov, S.I, Lanning, R.M, Sherman, E.J, Tsai, C.J, Riaz, N, McBride, S.M, Lee, N

Get full text

SLFN11 Is Necessary for Single Agent Sensitivity to Talazoparib, a Potent PARP Inhibitor, But Not for Radiosensitization in Small Cell Lung Cancer (SCLC) Cell Lines and Patient-Derived Xenografts (PDX) by Lok, B.H, Feng, Y, Gardner, E.E, Yu, G.K, Ru, Y.K, Riaz, N, deStanchina, E, Powell, S.N, Shen, Y.J, Poirier, J.T, Rudin, C.M

Get full text

Irradiation for Regionally Only Recurrent, Never-Irradiated Oral Cavity Cancers by Lok, B.H, Cai, X, Riaz, N, Leeman, J.E, Tsai, C.J, McBride, S.M, Higginson, D.S, Baxi, S.S, Sherman, E.J, Roman, B.R, Wong, R.J, Lee, N

Get full text

Genomic Analysis of Exceptional Responders to Low-Dose Radiation Therapy Reveals Somatic Mutations in ATM by Ma, J, Setton, J, Blecua Carrillo Albornoz, P, Barker, C.A, Lok, B.H, Beal, K, Powell, S.N, Lee, N, Chan, T.A, Riaz, N

Get full text

Palliative Head and Neck Radiation Therapy With the Quad Shot Regimen for Incurable Primary or Metastatic Cancers by Lok, B.H, Riaz, N, Lanning, R.M, Sridhara, S, Sherman, E.J, McBride, S.M, Rao, S.S, Lee, N.Y

Get full text

Metabolic Tumor Volume Is Superior to Gross Tumor Volume in Predicting Outcomes in Patients With Oropharyngeal Cancer Treated With IMRT by Romesser, P, Riaz, N, Lok, B.H, Setton, J, Rao, S, Lee, N.Y

Get full text

Age, Tumor Subtype, and Locoregional Recurrence in Operable Breast Cancer Patients Treated With Adjuvant Therapies by Lok, B.H, Morrow, M, Setton, J.S, Krause, K, Siu, C, Pei, X, Drill, E.N, Zhang, Z, Hudis, C.A, McCormick, B, Powell, S.N, Ho, A.Y

Get full text

The Effect of PARP Inhibitor Radiosensitization on the mRNA Translational Regulation of T Cell Chemokines by Ran, X., Zhang, X., Teng, M., Alawi, W.B., Nahum, S., He, H., Lok, B.H.

“…Immunotherapy has modestly improved survival for small cell lung cancer (SCLC) patients. Low response rate and rapid disease progression remain an intractable…”
Get full text

Phase I Trial of Concurrent Talazoparib and Consolidative Thoracic Radiotherapy for Patients with Extensive-Stage Small Cell Lung Cancer by Lok, B.H., Sacher, A.G., Bezjak, A., Raman, S., Hope, A.J., Sun, A., Leighl, N., Eng, L., Shepherd, F., Liu, G., Bradbury, P.

“…For patients with extensive-stage (ES) small cell lung cancer (SCLC), systemic therapy followed by low dose consolidative thoracic radiotherapy (CTRT) is a…”
Get full text

Cross-Cancer Analysis Reveals Distinct Pattern of Immune Modulation during Curative Radiotherapy by Said, B. Id, Boukhaled, G., Lok, B.H., Lukovic, J., Mesci, A., Waldron, J.N., Wong, P., Wang, B.X., Brooks, D.G., Milosevic, M.

“…Radiation therapy (RT) is a cornerstone in the curative treatment of solid tumors, yet its complex effects on the immune system are not fully understood. The…”
Get full text

Stereotactic Ablative Radiotherapy for Ultra-Central Lung Tumors: Local Control and Toxicity from a Seventeen-Year Single-Institution Experience by Safavi, S.A.H., Santiago, A.T., Torres, C., Raman, S., Lok, B.H., Hope, A.J., Bezjak, A., Sun, A.Y., Wu, G., Bissonnette, J.P., Cho, B.C.J., Giuliani, M.E.

“…Stereotactic ablative radiotherapy (SABR) for ultra-central (UC) lung tumors can be associated with morbidity and mortality. We report local control (LC) and…”
Get full text

TAK-243 Combined With Radiation And Other DNA Damaging Agents As A Novel Therapeutic Strategy For Small Cell Lung Cancer by Majeed, S., Aparnathi, M., Song, L., Weiss, J., Schimmer, A., Tsao, M., Liu, G., Lok, B.H.

Get full text

Dosimetric Predictors of Radiation Pneumonitis in Locally Advanced Non-Small Cell Lung Cancer Patients with Artificial-Intelligence Screened Interstitial Lung Disease by Bacon, H., McNeil, N., Patel, T., Welch, M., Ye, X.Y., Bezjak, A., Lok, B.H., Raman, S., Giuliani, M.E., Cho, J., Sun, A., Liu, G., Kandel, S., McIntosh, C., Tadic, T., Hope, A.J., Lindsay, P.E.

“…Radiation pneumonitis (RP) is a common and potentially severe complication following radiotherapy for locally advanced non-small cell lung cancer (NSCLC). We…”
Get full text

RAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination by Lok, B H, Carley, A C, Tchang, B, Powell, S N

“…Synthetic lethality is an approach to study selective cell killing based on genotype. Previous work in our laboratory has shown that loss of RAD52 is…”
Get full text

Stereotactic Radiation for Ultra-Central Non-Small Cell Lung Cancer: A Safety and Efficacy Trial (SUNSET) by Giuliani, M.E., Filion, E.J., Faria, S., Kundapur, V., Vu, T.T.T., Lok, B.H., Raman, S., Bahig, H., Laba, J.M., Lang, P., Louie, A., Hope, A., Rodrigues, G., Bezjak, A., Campeau, M.P., Duclos, M., Bratman, S., Swaminath, A., Warner, A., Palma, D.A.

Get full text

Primary Endpoint Results of NRG CC003: Phase IIR/III Trial of Prophylactic Cranial Irradiation (PCI) with or without Hippocampal Avoidance (HA) for Small Cell Lung Cancer (SCLC) by Gondi, V., Pugh, S., Mehta, M.P., Wefel, J.S., Tome, W.A., Sun, A., Videtic, G.M., Lok, B.H., Yoon, H.A., Heinzerling, J.H., DeNittis, A.S., McGarry, R.C., Devisetty, K., Kundapur, V., Wu, A.J., Paulus, R., Kachnic, L.A.

“…Prior randomized trials have demonstrated neurocognitive function (NCF) benefits of HA during whole-brain radiotherapy for non-SCLC brain metastases. NRG CC003…”
Get full text

Survival Outcomes of Extensive Stage Small Cell Lung Cancer Patients Treated with Consolidative Thoracic Radiotherapy at a Tertiary Cancer Center by Sugumar, V., Sr, R. R. Salunkhe, Ye, X.Y., Zhan, L., Sun, A., Bezjak, A., Cho, J., Raman, S., Hope, A.J., Giuliani, M.E., Leighl, N., Sacher, A.G., Shepherd, F., Bradbury, P., Liu, G., Lok, B.H.

“…Most small cell lung cancer cases present as Stage IV (M1) or extensive stage (ES-SCLC), which are defined as tumor extending outside the hemithorax without a…”
Get full text